University of Alberta Hospital, Edmonton, Alberta, Canada T6G 2B7.
J Crit Care. 2012 Jun;27(3):268-75. doi: 10.1016/j.jcrc.2011.06.003. Epub 2011 Jul 27.
Our objective was to describe the current practice for initiation of RRT in this population. There is uncertainty regarding the optimal time to initiate renal replacement therapy (RRT) in critically ill patients with acute kidney injury (AKI).
Prospective study of patients receiving RRT in 6 intensive care units (ICUs) at 3 hospitals from July 2007 to August 2008. We characterized factors associated with start of RRT and evaluated their relationship with mortality.
We included 234 patients. RRT was initiated 1 day (0-4) after ICU admission (median [interquartile range]). Median creatinine was 331 μmol/L (225-446 μmol/L), urea 22.9 mmol/L (13.9-32.9 mmol/L), and RIFLE-Failure in 76.9%. Of traditional indications, Pao(2)/Fio(2) < 200 (54.5%) and oliguria (32.9%) were most common. ICU and hospital mortality were 45.3% and 51.9%, respectively. In adjusted analysis, mortality at RRT initiation was associated with creatinine <332 μmol/L (odds ratio [OR] 2.8; 95% confidence interval [CI] 1.5-5.4), change in urea from admission >8.9 mmol/L (OR 1.8; 95% CI, 1.0-3.4), urine output <82 mL/24 hours (OR 3.0; 95% CI, 1.4-6.5), fluid balance >3.0 L/24 hours (OR 2.3; 95% CI, 1.2-4.5), percentage of fluid overload >5% (OR 2.3; 95% CI, 1.2-4.7), 3 or more failing organs (OR 4.5; 95% CI, 1.2-4.2), Sequential Organ Failure Assessment score >14 (OR 2.3; 95% CI, 1.3-4.3), and start 4 days or more after admission (OR 4.3; 95% CI, 1.9-9.5). Mortality was higher as factors accumulated.
In ICU patients requiring RRT, there was marked variation in factors that influence start of RRT. RRT initiation with fewer clinical triggers was associated with lower mortality. Timing of RRT may modify survival but requires appraisal in a randomized trial.
本研究旨在描述该人群中开始肾脏替代治疗(RRT)的当前实践。在急性肾损伤(AKI)的危重症患者中,开始肾脏替代治疗的最佳时间尚不确定。
对 2007 年 7 月至 2008 年 8 月期间在 3 家医院的 6 个重症监护病房(ICU)中接受 RRT 的患者进行前瞻性研究。我们描述了开始 RRT 的相关因素,并评估了它们与死亡率的关系。
共纳入 234 例患者。RRT 在 ICU 入院后 1 天(0-4 天)开始(中位数[四分位距])。中位数肌酐为 331μmol/L(225-446μmol/L),尿素 22.9mmol/L(13.9-32.9mmol/L),RIFLE-Failure 占 76.9%。在传统的适应证中,Pao2/Fio2<200(54.5%)和少尿(32.9%)最为常见。ICU 和住院死亡率分别为 45.3%和 51.9%。在调整分析中,RRT 开始时的死亡率与肌酐<332μmol/L(比值比[OR]2.8;95%置信区间[CI]1.5-5.4)、入院时尿素变化>8.9mmol/L(OR 1.8;95%CI,1.0-3.4)、尿量<82ml/24 小时(OR 3.0;95%CI,1.4-6.5)、液体平衡>3.0L/24 小时(OR 2.3;95%CI,1.2-4.5)、液体超负荷百分比>5%(OR 2.3;95%CI,1.2-4.7)、3 个或更多器官衰竭(OR 4.5;95%CI,1.2-4.2)、序贯器官衰竭评估(SOFA)评分>14(OR 2.3;95%CI,1.3-4.3)和入院 4 天或以上开始治疗(OR 4.3;95%CI,1.9-9.5)相关。随着因素的累积,死亡率更高。
在需要 RRT 的 ICU 患者中,影响开始 RRT 的因素存在明显差异。开始 RRT 时使用较少的临床触发因素与较低的死亡率相关。RRT 的时机可能会改变生存结果,但需要在随机试验中进行评估。